Summary Summary The dopamine hypothesis
The dopamine hypothesis has been the major pathophysiological has been the major pathophysiological theory of psychosis in recent decades. theory of psychosis in recent decades. Molecularimaging studies have provided Molecularimaging studies have provided in in vivo vivo evidence of increased dopamine evidence of increased dopamine synaptic availability and increased synaptic availability and increased presynaptic dopamine synthesis in the presynaptic dopamine synthesis in the striata of people with psychotic illnesses. striata of people with psychotic illnesses. These studies supportthe predictions of These studies supportthe predictions of the dopamine hypothesis, butit remains to the dopamine hypothesis, butit remains to be determined whether dopaminergic be determined whether dopaminergic abnormalities pre-date or are secondary abnormalities pre-date or are secondary to the development of psychosis. We to the development of psychosis. We selectively review the molecular imaging selectively review the molecular imaging studies ofthe striatal dopaminergic system studies ofthe striatal dopaminergic system in psychosis and link this to models of in psychosis and link this to models of psychosis and the functional subdivisions of psychosis and the functional subdivisions of the striatum to make predictions for the the striatum to make predictions for the dopaminergic system in the prodromal dopaminergic system in the prodromal phase of psychosis. phase of psychosis.
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THE DOPAMINE HYPOTHESIS THE DOPAMINE HYPOTHESIS OF PSYCHOSIS OF PSYCHOSIS
The predominant pathophysiological theory The predominant pathophysiological theory of psychosis postulates that dopamine dysof psychosis postulates that dopamine dysfunction is the final common pathway function is the final common pathway driving its development (Carlsson & driving its development (Carlsson & Lindqvist, 1963; Davis Lindqvist, 1963; Davis et al et al, 1991; Kapur, , 1991; Kapur, 2003) . It is hypothesised that hyperactivity 2003). It is hypothesised that hyperactivity of the dopamine system leads to the psyof the dopamine system leads to the psychotic symptoms seen in conditions such chotic symptoms seen in conditions such as schizophrenia (Kapur, 2003) . Recent elaas schizophrenia (Kapur, 2003) . Recent elaborations of this model propose that striborations of this model propose that striatal hyperdopaminergia results in aberrant atal hyperdopaminergia results in aberrant salience being attached to what would norsalience being attached to what would normally be innocuous stimuli that then form mally be innocuous stimuli that then form the basis of the hallucinations and delusions the basis of the hallucinations and delusions of psychosis (Kapur, 2003) . Additionally it of psychosis (Kapur, 2003) . Additionally it has been proposed that there is an interachas been proposed that there is an interaction between striatal dopamine overactivity tion between striatal dopamine overactivity and frontal dopamine hypoactivity, with and frontal dopamine hypoactivity, with the latter associated with some of the the latter associated with some of the neurocognitive deficits seen in schizoneurocognitive deficits seen in schizophrenia (Willner, 1997; Laruelle phrenia (Willner, 1997; Laruelle et al et al, , 2003; Abi-Dargham, 2004; ) . This is sup-2003; Abi-Dargham, 2004; ) . This is supported by a mouse model in which dopaported by a mouse model in which dopamine D2 receptor overexpression in the mine D2 receptor overexpression in the striatum is associated with selective workstriatum is associated with selective working memory deficits, and decreased dopaing memory deficits, and decreased dopamine turnover and D1 receptor activation mine turnover and D1 receptor activation in the frontal cortex (Kellendonk in the frontal cortex (Kellendonk et al et al, , 2006 (Kellendonk et al et al, , ). 2006 .
There is considerable indirect or There is considerable indirect or ex vivo ex vivo evidence of dopamine dysfunction in psyevidence of dopamine dysfunction in psychosis based on studies of dopaminergic chosis based on studies of dopaminergic agonists, antagonists, and post-mortem agonists, antagonists, and post-mortem studies reviewed by Carlsson and colleastudies reviewed by Carlsson and colleagues (Carlsson gues (Carlsson et al et al, 1997) . Pharmaco-, 1997) . Pharmacological studies show a correlation between logical studies show a correlation between clinical doses of antipsychotic drugs and clinical doses of antipsychotic drugs and their potency for blocking D2 receptors, their potency for blocking D2 receptors, and provide further evidence for the involand provide further evidence for the involvement of dopamine in psychosis through vement of dopamine in psychosis through the psychotogenic effects of dopamine the psychotogenic effects of dopamine enhancing drugs (Seeman & Lee, 1975; enhancing drugs (Seeman & Lee, 1975; Meltzer & Stahl, 1976; Haracz, 1982; Meltzer & Stahl, 1976; Haracz, 1982; Lieberman Lieberman et al et al, 1987) . These studies , 1987). These studies strongly suggest, but do not establish, the strongly suggest, but do not establish, the existence of a dysregulation of dopamine existence of a dysregulation of dopamine transmission in psychosis. Post-mortem transmission in psychosis. Post-mortem findings of chronic psychotic conditions findings of chronic psychotic conditions have been mixed. Although direct tissue have been mixed. Although direct tissue measures of dopamine and D2 receptor lemeasures of dopamine and D2 receptor levels have been found to be elevated in the vels have been found to be elevated in the striatum, this has not been consistent, and striatum, this has not been consistent, and post-mortem studies are confounded by post-mortem studies are confounded by antipsychotic exposure (Kleinman antipsychotic exposure (Kleinman et al et al, , 1988; Reynolds, 1989; Davis 1988; Reynolds, 1989; Davis et al et al, 1991; , 1991; Zakzanis & Hansen, 1998) . Zakzanis & Hansen, 1998 . The early studies in psychosis, predominantly schizophrenia, examined the striaminantly schizophrenia, examined the striatal postsynaptic dopamine D2 receptor tal postsynaptic dopamine D2 receptor density using positron emission tomogradensity using positron emission tomography (PET) and single photon emission phy (PET) (Crawley et al et al, 1986; Wong , 1986; Wong et al et al, , 1986; Gjedde & Wong, 1987) and others 1986; Gjedde & Wong, 1987) and others no difference from controls (Farde no difference from controls (Farde et al et al, , 1990; Martinot 1990; Martinot et al et al, 1990) . However a , 1990). However a meta-analysis of these studies concluded meta-analysis of these studies concluded that there is a modest elevation in the D2 that there is a modest elevation in the D2 receptor densities in people with psychotic receptor densities in people with psychotic illnesses, with an effect size of illnesses, with an effect size of approximately 0.5 (Laruelle, 1998) . The approximately 0.5 (Laruelle, 1998) . The two studies that have investigated D1 retwo studies that have investigated D1 receptor densities in the striatum of patients ceptor densities in the striatum of patients with psychotic illnesses report no difference with psychotic illnesses report no difference from controls, indicating that striatal D1 from controls, indicating that striatal D1 receptor levels are unchanged in psychosis, receptor levels are unchanged in psychosis, although there may be differences in other although there may be differences in other brain regions (Okubo brain regions (Okubo et al et al, 1997; Karlsson , 1997; Karlsson et al et al, 2002) . , 2002).
Other studies have examined the Other studies have examined the striatal synaptic availability and release striatal synaptic availability and release of dopamine (Laruelle of dopamine (Laruelle et al et al, 1996 (Laruelle et al et al, , 1999 , 1996 , 1999 These studies have used amphetamine to probe the responsivity of amphetamine to probe the responsivity of the striatal dopaminergic system. Amphetathe striatal dopaminergic system. Amphetamine acts to stimulate dopamine release mine acts to stimulate dopamine release from vesicles and reverse the dopamine from vesicles and reverse the dopamine transporter, increasing extracellular levels transporter, increasing extracellular levels of dopamine (Sulzer of dopamine (Sulzer et al et al, 1993; Jones , 1993; Jones et et al al, 1998 ). The competition model predicts , 1998). The competition model predicts that dopamine competes for binding to that dopamine competes for binding to the D2 receptors with the radioligand and the D2 receptors with the radioligand and therefore that the amphetamine-induced intherefore that the amphetamine-induced increase in dopamine levels results in a reduccrease in dopamine levels results in a reduction in radioligand binding and a change in tion in radioligand binding and a change in the signal compared to baseline conditions. the signal compared to baseline conditions. Stimulated dopamine release using amphetStimulated dopamine release using amphetamine has consistently been found to be amine has consistently been found to be increased in psychotic conditions by 1-2 increased in psychotic conditions by 1-2 standard deviations, and is related to both standard deviations, and is related to both the severity of induced psychotic symptoms, the severity of induced psychotic symptoms, and to the response to subsequent antiand to the response to subsequent antipsychotic treatment (Laruelle psychotic treatment (Laruelle et al, et al, 1996 (Laruelle et al, et al, , 1996 (Laruelle et al, et al, , 1999 Breier 1999; Breier et al et al, 1997; Abi-Dargham , 1997; Abi-Dargham et al et al, 1998) . However this increased radio-, 1998). However this increased radioligand displacement has not been seen in ligand displacement has not been seen in s13 s13 patients with schizophrenia during remispatients with schizophrenia during remission, suggesting that the increased dopasion, suggesting that the increased dopamine release is a feature of the psychotic mine release is a feature of the psychotic phases of the illness (Laruelle phases of the illness (Laruelle et al et al, 1999) . , 1999). These studies have been interpreted as These studies have been interpreted as indicating increased dopamine release, on indicating increased dopamine release, on the basis that animal studies show a correthe basis that animal studies show a correlation between increased dopamine concenlation between increased dopamine concentration as measured by microdialysis and tration as measured by microdialysis and radiotracer binding (Breier radiotracer binding (Breier et al et al, 1997; , 1997; Houston Houston et al et al, 2004) . To determine , 2004) . To determine whether baseline levels of dopamine are difwhether baseline levels of dopamine are different, Abi-Dargham and colleagues (2000) ferent, Abi-Dargham and colleagues (2000) examined the effect of dopamine depletion, examined the effect of dopamine depletion, using alpha-methyl-para-tyrosine, on using alpha-methyl-para-tyrosine, on [ [ I]IBZM binding following dopamine depletion in binding following dopamine depletion in first-episode psychosis and patients with first-episode psychosis and patients with chronic disorder during an acute relapse chronic disorder during an acute relapse compared with controls. This is taken as compared with controls. This is taken as indicating greater baseline D2 receptor indicating greater baseline D2 receptor occupancy by dopamine in psychosis. Addioccupancy by dopamine in psychosis. Additionally the degree of change correlated tionally the degree of change correlated with response to treatment with antiwith response to treatment with antipsychotics. Patients in remission need to psychotics. Patients in remission need to be studied to determine whether this is be studied to determine whether this is related to illness phase. related to illness phase.
Studies of presynaptic striatal Studies of presynaptic striatal dopaminergic function dopaminergic function
Presynaptic striatal dopaminergic function Presynaptic striatal dopaminergic function can be measured using the PET radiotracers can be measured using the PET radiotracers High Ki values occur in areas of dense dopamine nerve terminals such as dense dopamine nerve terminals such as the striatum, reflecting the structural and the striatum, reflecting the structural and functional integrity of the nigrostriatal functional integrity of the nigrostriatal dopaminergic system. Although tyrosine dopaminergic system. Although tyrosine hydroxylase, and not AADC, is the ratehydroxylase, and not AADC, is the ratelimiting step in the synthetic pathway for limiting step in the synthetic pathway for dopamine, AADC activity influences the dopamine, AADC activity influences the rate of dopamine synthesis (Cumming rate of dopamine synthesis (Cumming et et al al, 1995 (Cumming et et al al, , 1997 . FDOPA uptake has been , 1995, 1997). FDOPA uptake has been shown to correlate with nigral dopamine shown to correlate with nigral dopamine neuron numbers in both animal and human neuron numbers in both animal and human studies (Pate studies (Pate et al et al, 1993; Snow , 1993; Snow et al et al, 1993) . , 1993). These radiotracers have been used to invesThese radiotracers have been used to investigate the dopaminergic system in a number tigate the dopaminergic system in a number of central nervous system conditions, partiof central nervous system conditions, particularly Parkinson's Disease (Brooks, 1998; cularly Parkinson's Disease (Brooks, 1998; Morrish Morrish et al et al, 1998; Piccini and Brooks, , 1998; Piccini and Brooks, 1999; Brooks 1999; Brooks et al et al, 2000; Rakshi , 2000; Rakshi et al et al, , 2002 Rakshi et al et al, , ). 2002 .
Eight studies have measured pre-synapEight studies have measured pre-synaptic striatal dopamine synthesis and storage tic striatal dopamine synthesis and storage capacity using [ capacity using [b b--11 11 C]L-dopa or FDOPA C]L-dopa or FDOPA in psychotic conditions (Table 1) . Six found in psychotic conditions (Table 1) . Six found elevated striatal DOPA uptake in psychotic elevated striatal DOPA uptake in psychotic disorders (Reith disorders (Reith et al et al, 1994; Hietala , 1994; Hietala et al et al, , 1995 Hietala et al et al, , , 1999 Lindstrom 1995 Lindstrom , 1999 Lindstrom et al et al, 1999; , 1999; Meyer-Lindenberg Meyer-Lindenberg et al et al, 2002; McGowan , 2002; McGowan et al et al, 2004) , with effect sizes in the positive , 2004), with effect sizes in the positive studies ranging from 0.63 to 1.89. All stustudies ranging from 0.63 to 1.89. All studies that investigated patients who were dies that investigated patients who were psychotic at the time of PET scanning repsychotic at the time of PET scanning report elevated striatal dopamine synthesis port elevated striatal dopamine synthesis capacity (Hietala capacity (Hietala et al et al, 1995 (Hietala et al et al, , 1999 , 1995 , 1999 Lindstrom Lindstrom et al et al, 1999) . The two incon-, 1999). The two inconsistent studies were in chronically treated sistent studies were in chronically treated patients who were not acutely psychotic, patients who were not acutely psychotic, although Dao-Castellana and colleagues although Dao-Castellana and colleagues (1997) report a non-significant elevation (1997) report a non-significant elevation in the striatum and greater variance in the in the striatum and greater variance in the Ki values in the group with schizophrenia Ki values in the group with schizophrenia (Dao-Castellana (Dao-Castellana et al et al, 1997; Elkashef , 1997; Elkashef et al et al, , 2000) . The other study found a significant 2000). The other study found a significant decrease in Ki value in the ventral striatum decrease in Ki value in the ventral striatum of the group with untreated schizophrenia, of the group with untreated schizophrenia, but an increase in the posterior cingulate but an increase in the posterior cingulate (Elkashef (Elkashef et al et al, 2000) . Thus all the studies , 2000). Thus all the studies have found indications of increased DOPA have found indications of increased DOPA uptake in individuals with schizophrenia, uptake in individuals with schizophrenia, although not all in the striatum. although not all in the striatum.
Relationship between striatal Relationship between striatal dopamine synthesis capacity dopamine synthesis capacity and symptom profiles and symptom profiles There are indications that the elevation in There are indications that the elevation in dopamine synthesis capacity is not specific dopamine synthesis capacity is not specific to schizophrenia alone but is associated to schizophrenia alone but is associated with episodes of positive psychotic sympwith episodes of positive psychotic symptoms. Reith toms. Reith et al et al (1994) studied patients (1994) studied patients with complex partial seizures, and comwith complex partial seizures, and compared those with a history of psychosis to pared those with a history of psychosis to those who did not have a history of psychothose who did not have a history of psychosis. The group with psychosis showed elesis. The group with psychosis showed elevated striatal Ki values, similar to the vated striatal Ki values, similar to the elevation seen in a group with schizoelevation seen in a group with schizophrenia, while the striatal Ki value in the phrenia, while the striatal Ki value in the non-psychotic group was similar to that in non-psychotic group was similar to that in controls (Reith controls (Reith et al et al, 1994) . Hietala and , 1994) . Hietala and colleagues (1995) have suggested that there colleagues (1995) have suggested that there is a difference in FDOPA uptake which is a difference in FDOPA uptake which depends on the subtype of schizophrenia. depends on the subtype of schizophrenia.
This was based on the finding that a single This was based on the finding that a single subject with catatonia showed markedly subject with catatonia showed markedly lower striatal FDOPA uptake than controls lower striatal FDOPA uptake than controls and those with paranoid schizophrenia. and those with paranoid schizophrenia. Dao-Castellana Dao-Castellana et al et al (1997) subsequently (1997) subsequently found a similar reduction in a subject with found a similar reduction in a subject with catatonia. Hietala and colleagues (1999) catatonia. Hietala and colleagues (1999) also found a negative correlation between also found a negative correlation between depressive symptoms and striatal FDOPA depressive symptoms and striatal FDOPA uptake, and a trend for positive psychotic uptake, and a trend for positive psychotic symptoms to be associated with higher symptoms to be associated with higher striatal FDOPA uptake. Further support striatal FDOPA uptake. Further support for elevated FDOPA uptake being assofor elevated FDOPA uptake being associated with positive psychotic symptoms ciated with positive psychotic symptoms could be inferred from the two studies could be inferred from the two studies that found no significant elevation in that found no significant elevation in et al, 1995 , 1999 Lindstrom , 1995 Lindstrom , , 1999 Lindstrom et et al al, 1999) . Furthermore the findings repor-, 1999). Furthermore the findings reported by Hietala ted by Hietala et al et al (1999) supporting an (1999) supporting an association between positive psychotic association between positive psychotic symptoms and elevated FDOPA uptake symptoms and elevated FDOPA uptake are at a trend level in small groups of are at a trend level in small groups of patients, indicating that further studies are patients, indicating that further studies are needed to determine if the association is needed to determine if the association is found in other samples. found in other samples.
SPECIFICITY OF STRIATAL SPECIFICITY OF STRIATAL DOPAMINERGIC DOPAMINERGIC ABNORMALITIES ABNORMALITIES TO PSYCHOSIS TO PSYCHOSIS
Striatal dopaminergic function is not eleStriatal dopaminergic function is not elevated in non-psychotic patients with other vated in non-psychotic patients with other psychiatric or neurological conditions, psychiatric or neurological conditions, including mania (without psychotic sympincluding mania (without psychotic symptoms), Tourette's syndrome and depression toms), Tourette's syndrome and depression (Reith (Reith et al et al, 1994; Turjanski , 1994; Turjanski et al et al, 1994; , 1994; Ernst Ernst et al et al, 1997; Martinot , 1997; Martinot et al et al, 2001; , 2001; Parsey Parsey et al et al, 2001; Yatham , 2001; Yatham et al et al, 2002) . , 2002). Ernst and colleagues Ernst and colleagues report no significant report no significant difference in striatal FDOPA uptake difference in striatal FDOPA uptake between children or adults with attentionbetween children or adults with attentiondeficit hyperactivity disorder and controls, deficit hyperactivity disorder and controls, although there may be differences in other although there may be differences in other brain regions (Ernst brain regions (Ernst et al et al, 1998 (Ernst et al et al, , 1999 (Ernst et al et al, ). , 1998 (Ernst et al et al, , 1999 . The findings in these studies indicate that The findings in these studies indicate that s14 s14 elevated presynaptic elevated presynaptic striatal dopamine striatal dopamine synthesis capacity is not a non-specific indisynthesis capacity is not a non-specific indicator of stress or psychiatric/ neurological cator of stress or psychiatric/ neurological morbidity. morbidity.
DOPAMINE DOPAMINE AND THE PRODROMAL PHASE AND THE PRODROMAL PHASE OF PSYCHOSIS OF PSYCHOSIS
Prior to the development of psychosis, the Prior to the development of psychosis, the majority of patients experience a prodromajority of patients experience a prodromal phase characterised by functional mal phase characterised by functional decline and subclinical symptoms (Hafner, decline and subclinical symptoms (Hafner, 1998) , 2003) , identifies people with an at-risk 2003), identifies people with an at-risk mental state using the Personal Assessment mental state using the Personal Assessment and Crises Evaluation (PACE) criteria who and Crises Evaluation (PACE) criteria who have a 20-40% probability of being in a have a 20-40% probability of being in a prodromal state and developing a psychotic prodromal state and developing a psychotic illness within 1 year, indicating that they illness within 1 year, indicating that they are at ultra high risk of psychosis (UHRP). are at ultra high risk of psychosis (UHRP). Most subjects meeting CAARMS criteria Most subjects meeting CAARMS criteria for an at-risk mental state experience for an at-risk mental state experience 'attenuated symptoms', which correspond 'attenuated symptoms', which correspond to positive psychotic symptoms that are to positive psychotic symptoms that are not as severe and/or frequent as in an acute not as severe and/or frequent as in an acute psychotic disorder. Less commonly individpsychotic disorder. Less commonly individuals with an at-risk mental state experience uals with an at-risk mental state experience brief limited intermittent psychotic sympbrief limited intermittent psychotic symptoms (BLIPS), which are full-blown but toms (BLIPS), which are full-blown but brief psychotic episodes that spontaneously brief psychotic episodes that spontaneously resolve after 1 week or less. The presence of resolve after 1 week or less. The presence of positive psychotic symptoms in an at-risk positive psychotic symptoms in an at-risk mental state group defined using the mental state group defined using the CAARMS, albeit the psychotic symptoms CAARMS, albeit the psychotic symptoms show a lesser severity, frequency or durashow a lesser severity, frequency or duration than in acute psychotic disorders, is tion than in acute psychotic disorders, is consistent with a perturbation of dopamine consistent with a perturbation of dopamine function. However, the at-risk mental state function. However, the at-risk mental state can be defined in different ways, and the can be defined in different ways, and the CAARMS criteria are weighted towards CAARMS criteria are weighted towards positive symptoms relative to other features positive symptoms relative to other features of the at-risk mental state, such as negative of the at-risk mental state, such as negative symptoms and subjective cognitive impairsymptoms and subjective cognitive impair- . Although molecular imaging studies Although molecular imaging studies provide evidence of striatal hyperdopamiprovide evidence of striatal hyperdopaminergia in patients with an established psynergia in patients with an established psychotic disorder, no studies have been chotic disorder, no studies have been published to date using molecular imaging published to date using molecular imaging to assess striatal dopaminergic function beto assess striatal dopaminergic function before the onset of psychosis in people with fore the onset of psychosis in people with an at-risk mental state, who are at high risk an at-risk mental state, who are at high risk of imminently developing psychosis. of imminently developing psychosis.
Subjects with an at-risk mental state are Subjects with an at-risk mental state are experiencing attenuated psychotic sympexperiencing attenuated psychotic symptoms and are also at high risk of developing toms and are also at high risk of developing psychosis in the near future, therefore an psychosis in the near future, therefore an initial prediction would be that the at-risk initial prediction would be that the at-risk mental state would be associated with striamental state would be associated with striatal hyperdopaminergia. However, as most tal hyperdopaminergia. However, as most individuals with an at-risk mental state will individuals with an at-risk mental state will not develop a psychotic illness, a further not develop a psychotic illness, a further prediction might be that the magnitude of prediction might be that the magnitude of this elevation will be greater in those that this elevation will be greater in those that go on to develop a psychotic illness than go on to develop a psychotic illness than in subjects who do not. in subjects who do not.
Models of psychosis (above) propose Models of psychosis (above) propose that elevated dopaminergic function may that elevated dopaminergic function may lead to the development of hallucinations lead to the development of hallucinations and delusions through effects on cognitive and delusions through effects on cognitive processes like appraisal. Reasoning is a processes like appraisal. Reasoning is a component of appraisal and those with atcomponent of appraisal and those with atrisk mental state show a bias in probabilisrisk mental state show a bias in probabilistic reasoning ('jumping to conclusions') tic reasoning ('jumping to conclusions') that is similar to that seen in psychotic disthat is similar to that seen in psychotic disorders (Garety orders (Garety et al et al, 2005; Peters & Garety, , 2005; Peters & Garety, 2006) . This suggests that the magnitude of 2006). This suggests that the magnitude of the hypothesised increase in dopaminergic the hypothesised increase in dopaminergic function may be correlated with a tendency function may be correlated with a tendency to jump to conclusions. In addition, beto jump to conclusions. In addition, because elevated dopaminergic function may cause elevated dopaminergic function may be specifically linked to hallucinations and be specifically linked to hallucinations and delusions, hyperdopaminergia in the at-risk delusions, hyperdopaminergia in the at-risk mental state would be predicted to be partimental state would be predicted to be particularly correlated with the severity of these cularly correlated with the severity of these symptoms as opposed to other psychotic symptoms as opposed to other psychotic features or the level of general psychofeatures or the level of general psychopathology. pathology.
Finally, it has been suggested that the Finally, it has been suggested that the cognitive impairment and negative sympcognitive impairment and negative symptoms of schizophrenia are a function of toms of schizophrenia are a function of hypodopaminergia in the dorsolateral prehypodopaminergia in the dorsolateral prefrontal cortex (Abi-Dargham frontal cortex (Abi-Dargham et al et al, 2002) . , 2002). It is difficult to assess cortical dopamine It is difficult to assess cortical dopamine function using FDOPA due to its low signalfunction using FDOPA due to its low signalto-noise ratio in the cortex (McGowan to-noise ratio in the cortex (McGowan et et al al, 2004) . However, it has been proposed , 2004). However, it has been proposed that hypodopaminergia in the dorsolateral that hypodopaminergia in the dorsolateral prefrontal cortex in schizophrenia is related prefrontal cortex in schizophrenia is related to excess subcortical dopamine levels to excess subcortical dopamine levels (Tanaka, 2006) , and striatal FDOPA (Tanaka, 2006) , and striatal FDOPA uptake in patients with schizophrenia has uptake in patients with schizophrenia has been inversely correlated with dorsolateral been inversely correlated with dorsolateral prefrontal cortex activation during the prefrontal cortex activation during the Wisconsin Card Sort test (Meyer-Lindenberg Wisconsin Card Sort test (Meyer-Lindenberg et al et al, 2002) and with impaired performance , 2002) and with impaired performance s1 5 s1 5 M, male; F, female; FE, first episode; C, chronic; M, mixed first episode and chronic patients; N, antipsychotic treatment na|ve; DF, antipsychotic drug free at time of scan but M, male; F, female; FE, first episode; C, chronic; M, mixed first episode and chronic patients; N, antipsychotic treatment na|« ve; DF, antipsychotic drug free at time of scan but previously treated; A, taking antipsychotic treatment at time of scan. previously treated; A, taking antipsychotic treatment at time of scan. 1. Includes patients with schizoaffective disorder ( 1. Includes patients with schizoaffective disorder (n n¼5 for all studies). 5 for all studies). 2. Includes patients with schizophreniform psychosis. 2. Includes patients with schizophreniform psychosis. 3. 3. P P-value for the analysis reported (for a -value for the analysis reported (for a¼whole striatum, b whole striatum, b¼caudate, or c caudate, or c¼putamen. putamen. 4. Mean for combined patient group. 4. Mean for combined patient group.
on the symbol-digit modalities test on the symbol-digit modalities test (McGowan (McGowan et al et al, 2004) . Thus the hypo-, 2004). Thus the hypothesised increase in striatal dopaminergic thesised increase in striatal dopaminergic function in the at-risk mental state may be function in the at-risk mental state may be inversely correlated with impaired preinversely correlated with impaired prefrontal cortical function, as indicated frontal cortical function, as indicated through impaired performance on tasks of through impaired performance on tasks of executive functions and by abnormal dorsoexecutive functions and by abnormal dorsolateral prefrontal cortex activation in lateral prefrontal cortex activation in functional neuroimaging studies. functional neuroimaging studies.
FUNCTIONAL SUBDIVISIONS FUNCTIONAL SUBDIVISIONS OF THE STRIATUM OF THE STRIATUM
The striatum shows a topographic organiThe striatum shows a topographic organisation reflecting connections with the sation reflecting connections with the limbic, frontal executive and motor brain limbic, frontal executive and motor brain regions that does not correspond to regions that does not correspond to traditional anatomical subdivisions into traditional anatomical subdivisions into caudate, putamen and nucleus accumbens caudate, putamen and nucleus accumbens (Haber, 2003) . Ventral areas of the stri- (Haber, 2003) . Ventral areas of the striatum (the nucleus accumbens, and ventral atum (the nucleus accumbens, and ventral caudate and putamen rostral to the anterior caudate and putamen rostral to the anterior commissure) are part of limbic circuits incommissure) are part of limbic circuits involving medial prefrontal and orbitofrontal volving medial prefrontal and orbitofrontal cortex, and thalamic loops, and have been cortex, and thalamic loops, and have been termed the 'limbic striatum' (Joel & Weiner, termed the 'limbic striatum' (Joel & Weiner, 2000; Martinez 2000; Martinez et al et al, 2003) . The dorsal , 2003) . The dorsal areas of the caudate and putamen rostral areas of the caudate and putamen rostral to the anterior commissure and the postto the anterior commissure and the postcommissural caudate form circuits involcommissural caudate form circuits involving the dorsolateral prefrontal cortex, ving the dorsolateral prefrontal cortex, and ventral anterior thalamus, and are and ventral anterior thalamus, and are involved in cognitive function ('the associainvolved in cognitive function ('the associative striatum') (Joel & Weiner, 2000; tive striatum') (Joel & Weiner, 2000; Martinez Martinez et al et al, 2003) . Finally the post- , 2003) . Finally the postcommissural putamen ('the sensorimotor commissural putamen ('the sensorimotor striatum') is linked to the motor and prestriatum') is linked to the motor and premotor cortex and ventral anterior thalamus motor cortex and ventral anterior thalamus (Joel & Weiner, 2000; Martinez (Joel & Weiner, 2000; Martinez et al et al, , 2003 Martinez et al et al, , ). 2003 .
Striatal functional connectivity suggests Striatal functional connectivity suggests that the consequences of dopaminergic dysthat the consequences of dopaminergic dysfunction may vary depending on the area of function may vary depending on the area of the striatum affected. Because of its place in the striatum affected. Because of its place in circuits involving the dorsolateral prefrontal circuits involving the dorsolateral prefrontal cortex, the associative striatum would be cortex, the associative striatum would be predicted to be critical to the cognitive propredicted to be critical to the cognitive processes leading to psychosis, and the cognicesses leading to psychosis, and the cognitive dysfunction seen in schizophrenia. tive dysfunction seen in schizophrenia. Recent advances in imaging technology Recent advances in imaging technology have enabled these functional subdivisions have enabled these functional subdivisions to be delineated (Martinez to be delineated (Martinez et al et al, 2003) . , 2003) . Preliminary evidence has recently been Preliminary evidence has recently been presented indicating that the alphapresented indicating that the alphamethyl-para-tyrosine induced increase in methyl-para-tyrosine induced increase in D2 receptor availability was significantly D2 receptor availability was significantly higher in the associative striatum of higher in the associative striatum of patients with schizophrenia, but not the patients with schizophrenia, but not the other striatal subregions (Laruelle, 2006) . other striatal subregions (Laruelle, 2006 C]raclopride displacement seen in the C]raclopride displacement seen in the schizotypal personality disorder group was schizotypal personality disorder group was similar to that seen in remitted patients similar to that seen in remitted patients with schizophrenia, but much less than that with schizophrenia, but much less than that seen in patients with acute psychosis. seen in patients with acute psychosis.
The investigation of striatal dopaminThe investigation of striatal dopaminergic function in individuals with an at-risk ergic function in individuals with an at-risk mental state has a number of advantages mental state has a number of advantages over further studies of striatal dopaminergic over further studies of striatal dopaminergic function in people with psychotic illnesses. function in people with psychotic illnesses. Firstly it will help determine the time-point Firstly it will help determine the time-point at which dopaminergic abnormalities occur, at which dopaminergic abnormalities occur, indicating whether dopaminergic abnormalindicating whether dopaminergic abnormalities are primary or secondary to other facities are primary or secondary to other factors. Similarly the relationship between tors. Similarly the relationship between dopaminergic function and cognitive prodopaminergic function and cognitive processes thought to be related to the developcesses thought to be related to the development of psychosis, and the development of ment of psychosis, and the development of the cognitive deficits seen in psychosis, the cognitive deficits seen in psychosis, can be investigated. Additionally the effects can be investigated. Additionally the effects of antipsychotic drugs on dopaminergic of antipsychotic drugs on dopaminergic function are not a complicating factor as function are not a complicating factor as this group is largely antipsychotic naıve, this group is largely antipsychotic naïve, and a substantial proportion of individuals and a substantial proportion of individuals with an at-risk mental state are in the prowith an at-risk mental state are in the prodromal phase of a psychotic illness, which dromal phase of a psychotic illness, which is not the case in other 'risk groups', such is not the case in other 'risk groups', such as relatives of those with schizophrenia or as relatives of those with schizophrenia or people with schizotypy, as these groups people with schizotypy, as these groups contain many individuals who may be trait contain many individuals who may be trait carriers but who will not develop psychosis. carriers but who will not develop psychosis. There has been considerable debate conThere has been considerable debate concerning the ethics of offering people with cerning the ethics of offering people with an at-risk mental state antipsychotic median at-risk mental state antipsychotic medication to treat attenuated psychotic sympcation to treat attenuated psychotic symptoms and reduce the risk of developing toms and reduce the risk of developing psychotic illness (McGorry psychotic illness (McGorry et al et al, 2001; , 2001; Haroun Haroun et al et al, 2006) . Studies of the dopami-, 2006). Studies of the dopaminergic system in individuals with an at-risk nergic system in individuals with an at-risk mental state would indicate whether a domental state would indicate whether a dopaminergic abnormality that might be modpaminergic abnormality that might be modified by antipsychotic treatment exists prior ified by antipsychotic treatment exists prior to the development of psychosis. to the development of psychosis.
CONCLUSIONS CONCLUSIONS
There is a fairly substantial and consistent There is a fairly substantial and consistent body of body of in vivo in vivo molecular imaging evidence molecular imaging evidence indicating that striatal presynaptic dopaindicating that striatal presynaptic dopamine synthesis and synaptic dopamine mine synthesis and synaptic dopamine availability is increased in psychotic illavailability is increased in psychotic illnesses. Striatal dopamine D2 receptor levels nesses. Striatal dopamine D2 receptor levels may also be modestly increased in people may also be modestly increased in people with psychotic illnesses, although there with psychotic illnesses, although there have been a number of inconsistent studies, have been a number of inconsistent studies, and striatal D1 receptor levels are similar. and striatal D1 receptor levels are similar. The relationship between psychotic sympThe relationship between psychotic symptoms and dopaminergic function is less well toms and dopaminergic function is less well established, as few studies have investigated established, as few studies have investigated this, and the results among those to have this, and the results among those to have done so are inconsistent. Although the done so are inconsistent. Although the imaging data reviewed supports the dopaimaging data reviewed supports the dopamine hypothesis, the studies cannot exclude mine hypothesis, the studies cannot exclude the possibility that the abnormalities in the the possibility that the abnormalities in the dopamine system are secondary to other dopamine system are secondary to other factors, such as glutamatergic dysfunction factors, such as glutamatergic dysfunction (Laruelle (Laruelle et al et al, 2003) . Studies in people , 2003) . Studies in people with at-risk mental states, some of whom with at-risk mental states, some of whom are in the prodromal phase of psychosis, are in the prodromal phase of psychosis, are needed to determine whether the dopaare needed to determine whether the dopaminergic abnormalities found in psychotic minergic abnormalities found in psychotic illness are state or trait features. Furtherillness are state or trait features. Furthermore these studies will enable a number more these studies will enable a number of predictions about the relationship beof predictions about the relationship between dopaminergic abnormalities and tween dopaminergic abnormalities and cognitive biases and cognitive impairments cognitive biases and cognitive impairments commonly associated with psychosis to be commonly associated with psychosis to be tested. Investigating the pathophysiology tested. Investigating the pathophysiology of the prodromal phase is important both of the prodromal phase is important both to understand the pathophysiology of to understand the pathophysiology of psychosis and for the development of better psychosis and for the development of better treatments to prevent the development of treatments to prevent the development of psychosis and ameliorate symptoms in the psychosis and ameliorate symptoms in the prodrome. prodrome.
